The German defense electronics specialist Hensoldt finds itself grappling with a high-class problem that has escalated into a significant operational challenge. The company’s order books are overflowing, yet translating this demand into delivered products and revenue has proven difficult. In a swift strategic move, the firm is launching a two-pronged offensive—combining an acquisition in the Netherlands with a factory expansion at home—aimed at converting its massive order backlog into tangible financial results.
Management and Major Investors Signal Confidence
Internal signals point to strong belief in the company’s trajectory. CEO Oliver Dörre, whose contract was recently extended ahead of schedule through to 2031, made a personal investment by purchasing shares worth approximately €75,000. This move was paralleled by investment giant BlackRock, which increased its voting rights stake to over 5%. Market observers frequently interpret such synchronized actions by leadership and major institutional investors as an indicator of faith in the underlying corporate strategy.
A Rapid-Fire Capacity Expansion Plan
Management moved decisively, creating facts on the ground within a mere 24-hour period. On March 5, the acquisition of Dutch specialist Nedinsco was finalized. The very next day, plans were solidified for a site expansion in Aalen, Germany. The integration of Nedinsco represents a logical step in securing Hensoldt’s supply chain, given the two companies have collaborated for two decades. This deal grants Hensoldt direct access to critical optical components, availability of which has often been a bottleneck in manufacturing complex periscope systems.
Concurrently, the company is in advanced negotiations for the Triumph site in Aalen. The objective is to provide more space for the dynamically growing optronics division, facilitating both development and manufacturing. This dual offensive is deemed essential to bridge the growing gap between commercial success and production capability.
Should investors sell immediately? Or is it worth buying Hensoldt?
The Growing Chasm Between Orders and Revenue
The urgency of the situation is starkly illustrated by the firm’s 2025 figures. While order intake exploded by an impressive 62% to over €4.7 billion, revenue growth lagged significantly, increasing by just under 10%. This widening divergence is tempering investor enthusiasm. The share price, which closed at €74.10 on Friday, reflects this cautious wait-and-see attitude. Since the start of the year, the stock has recorded a slight decline of 3.01%, as the market demands evidence of backlog execution, not just a full order book.
Despite these operational bottlenecks, profitability has remained robust. Hensoldt surpassed its own forecast with an adjusted EBITDA margin of 18.4%. This performance demonstrates that when products are delivered, the financials are solid.
Concrete Financial Outlook and Key Dates
For the current 2026 financial year, management has provided revenue guidance of approximately €2.75 billion. This projection sits slightly below the expectations of some analysts but is accompanied by a sweetener: an increased dividend of €0.55 per share.
The strategic course is set; the real test now lies in execution. Investors would be wise to mark two key dates on their calendars: March 26, for the release of the audited annual financial statements, and May 6, for the first-quarter results. These events will deliver the first concrete data on whether the “North Star” strategy is gaining traction and if the process of working through the €8.8 billion mountain of orders is finally accelerating.
Ad
Hensoldt Stock: Buy or Sell?! New Hensoldt Analysis from March 8 delivers the answer:
The latest Hensoldt figures speak for themselves: Urgent action needed for Hensoldt investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 8.
Hensoldt: Buy or sell? Read more here...
